High glucose initiates calpain-induced necrosis before apoptosis in LLC-PK1 cells

Kidney International

Volumn 71, Issue 7, 2007, Pages 655-663

  Harwood, S M ^a   Allen, D A ^a   Raftery, M J ^a   Yaqoob, M M ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Apoptosis; Cell death; Hyperglycemia; Oxidative stress; Proximal tubule

Indexed keywords

CALPAIN; GLUCOSE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SMALL INTERFERING RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL STRAIN; CONTROLLED STUDY; DNA NICK TRANSLATION; ENZYME ACTIVITY; GLUCOSE INTAKE; KIDNEY PROXIMAL TUBULE; NECROSIS; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ANIMALS; APOPTOSIS; CALPAIN; EPITHELIAL CELLS; GLUCOSE; KIDNEY TUBULES, PROXIMAL; LLC-PK1 CELLS; NECROSIS; SWINE;

EID: 33947661527     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002106     Document Type: Article

References (49)

1. Allen DA, Harwood SM, Varagunam M et al. High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases. FASEB J 2003; 17: 908-910.
2. Du X, Matsumura T, Edelstein D et al. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest 2003; 112: 1049-1057.
3. Sirover MA. New nuclear functions of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in mammalian cells. J Cell Biochem 2005; 95: 45-52.
4. Brownlee M. The pathobiology of diabetic complications. Diabetes 2005; 54: 1615-1625.
5. Reusch JEB. Diabetes, microvascular complications: what is it about glucose? J Clin Invest 2003; 112: 986-988.
6. Valencia A, Moran J. Reactive oxygen species induces different cell death mechanisms in cultured neurons. Free Rad Biol Med 2004; 36: 1112-1125.
7. Thuraisingham RC, Nott CA, Dodd SM, Yaqoob MM. Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy. Kidney Int 2000; 57: 1968-1972.
8. Onozato ML, Tojo A, Goto A et al. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int 2002; 61: 186-194.
9. Drel VR, Pacher P, Stevens MJ, Obrosova IG. Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high glucose-exposed human mesangial cells. Free Rad Biol Med 2006; 40: 1454-1465.
10. Yuet-Ching T, Wang Y, Kairaitis L et al. Can murine nephropathy be separated from superimposed acute renal failure? Kidney Int 2005; 68: 393-398.
11. Boldizsár F, Berki T, Miseta A, Németh P. Effects of hyperglycemia on the basal cytosolic free calcium level, calcium signal and tyrosine-phosphorylation in human T-cells. Immunol Lett 2002; 82: 159-164.
12. 2+ uptake in the presence of high glucose in renal proximal tubule cells. Clin Exper Pharmacol Physiol 2003; 30: 694-701.
13. Dragomir E, Manduteanu I, Voinea M et al. Aspirin rectifies calcium homeostasis, decreases reactive oxygen species, and increases NO production in high glucose-exposed human endothelial cells. J Diabetes Complicat 2004; 18: 289-299.
14. + channel 6.2 (SUR/Kir6.2) selective potassium channel opener in human islets. Diabetes 2004; 53: 1706-1713.
15. Moriyama R, Tsukamura H, Kinoshita M et al. In vitro increase in intracellular calcium concentrations induced by low or high extracellular glucose levels in ependymocytes and serotonergic neurons of the rat lower brainstem. Endocrinology 2004; 145: 2507-2515.
16. 2+ channels are involved in high glucose-induced rat neonatal cardiomyocyte proliferation. Pediatr Res 2005; 57: 550-556.
17. Morais C, Westhuyzen J, Pat B et al. High ambient glucose is effect-neutral on cell death and proliferation in human proximal tubular epithelial cells. Am J Physiol Renal Physiol 2005; 289: F401-F409.
18. Du Y, Miller CM, Kern TS. Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Rad Biol Med 2003; 35: 1491-1499.
19. Verzola D, Bertolotto MB, Villaggio B et al. Oxidative stress mediates apoptotic changes induced by hyperglycemia in human tubular kidney cells. J Am Soc Nephrol 2004; 15: S85-S87.
20. Mishra R, Emancipator SN, Kern T, Simonson MS. High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells. Kidney Int 2005; 67: 82-93.
21. Soriano FG, Virag L, Jagtap P et al. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med 2001; 7: 108-113.
22. Vincent AM, Olzmann JA, Brownlee M et al. Uncoupling proteins prevent glucose-induced neuronal oxidative stress and programmed cell death. Diabetes 2004; 53: 726-734.
23. Vincent AM, McLean LL, Backus C, Felman EL. Short-term hyperglycemia produced oxidative damage and apoptosis in neurons. FASEB J 2005; 19: 638-640.
24. Kang Y-H, Yi M-J, Kim M-J et al. Caspase-independent cell death by arsenic trioxide in human cervical cancer cells: reactive oxygen species-mediated poly(ADP-ribose) polymerase-1 activation signals apoptosis-induced factor release from mitochondria. Cancer Res 2004; 64: 8960-8967.
25. Colston JT, de la Rosa SD, Freeman GL. Impact of brief oxidant stress on primary adult cardiac fibroblasts. Biochem Biophys Res Commun 2004; 316: 256-262.
26. Hwang SY, Paik S, Park SH et al. N-phenethyl-2-phenylacetamide isolated from Xenorhabdus nematophilus induces apoptosis through caspase activation and calpain-mediated Bax cleavage in U937 cells. Int J Oncol 2003; 22: 151-157.
27. Altznauer F, Conus S, Cavalli A. Calpain-1 regulates Bax and subsequent Smac-dependent caspase-3 activation in neutrophil apoptosis. J Biol Chem 2004; 279: 5947-5957.
28. Vaisid T, Kosower NS, Barnoy S. Caspase-1 activity is required for neuronal differentiation of PC12 cells: cross-talk between the caspase and calpain systems. Biochim Biophys Acta 2005; 1743: 223-230.
29. Blomgren K, Zhu C, Wang X et al. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis". J Biol Chem 2001; 276: 10191-10198.
30. Nakagawa T, Zhu H, Morishima N et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 2000; 403: 98-103.
31. Kobayashi S, Fujihara M, Hoshino N. Diabetic state-induced activation of calcium-activated neutral proteinase in mouse skeletal muscle. Endocrinol Japan 1989; 36: 833-844.
32. Sakamoto-Mizutani K, Fukiage C, Tamada Y et al. Contribution of ubiquitous calpains to cataractogenesis in spontaneous diabetic WBN/Kob rat. Exp Eye Res 2002; 75: 611-617.
33. Stalker TJ, Skvarka CB, Stone R. A novel role for calpains in the endothelial dysfunction of hyperglycemia. FASEB J 2003; 17: 1511-1513.
34. Stalker TJ, Gong Y, Scalia R. The calcium-dependent protease calpain causes endothelial dysfunction in type 2 diabetes. Diabetes 2005; 54: 1132-1140.
35. Wang KKW, Posmantur R, Nadimpalli R et al. Caspase-mediated fragmentation of calpain inhibitor protein calpastatin during apoptosis. Arch Biochem Biophys 1998; 356: 187-196.
36. Porn-Ares MI, Samali A, Orrenius S. Cleavage of the calpain inhibitor, calpastatin, during apoptosis. Cell Death Differ 1998; 5: 1028-1033.
37. Kato M, Nonaka T, Maki M et al. Caspases cleave the amino-terminal calpain inhibitory unit of calpastatin during apoptosis in human Jurkat T cells. J Biochem 2000; 127: 297-305.
38. Neumar RW, Xu YA, Gada H et al. Cross-talk between calpain and caspase proteolytic systems during neuronal apoptosis. J Biol Chem 2003; 278: 14162-14167.
39. Ruiz-Vela A, Gonzalez de Buitrago G, Martinez-A C. Implication of calpain in caspase activation during B cell clonal deletion. EMBO J 1999; 18: 4988-4998.
40. Chua BT, Guo K, Peng L. Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases. J Biol Chem 2000; 275: 5131-5135.
41. Nakagawa T, Yuan J. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol 2000; 150: 887-894.
42. Barnoy S, Kosower NS. Caspase-1 induced calpastatin degradation in myoblast differentiation and fusion: cross-talk between the caspase and calpain systems. FEBS Lett 2003; 546: 213-217.
43. Horikawa Y, Oda N, Cox NJ et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000; 26: 163-175.
44. Cox NJ, Hayes MG, Roe CA et al. Linkage of calpain 10 to type 2 diabetes: the biological rationale. Diabetes 2004; 53: S19-S25.
45. Ma H, Fukiage C, Kim YH et al. Characterization and expression of calpain 10. A novel ubiquitous calpain with nuclear localization. J Biol Chem 2001; 276: 28525-28531.
46. Thompson VF, Goll DE. Purification of mu-calpain, m-calpain, and calpastatin from animal tissue. Methods Mol Biol 2000; 144: 3-16.
47. Harwood SM, Allen DA, Raftery MJ et al. Calpain is a mediator of myocardial injury in experimental uremia: is it activated by endogenous ouabain? Kidney Int 2003; 63: S177-S180.
48. Harwood SM, Allen DA, Chesser AMS et al. Calpain is activated in experimental uremia: is calpain a mediator of uremia-induced myocardial injury? Kidney Int 2003; 63: 866-877.
49. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-3450.